id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0278-0006,FDA,FDA-2007-E-0278,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOLINZA,Notice,N-Notice,2008-05-14T04:00:00Z,2008,5,2008-05-14T04:00:00Z,2008-07-15T03:59:59Z,2008-05-14T13:07:11Z,E8-10689,0,0,09000064805b7e34
FDA-2007-E-0278-0005,FDA,FDA-2007-E-0278,FDA Center for Drug Evaluation and Research to the USPTO - Letter,Other,LET-Letter,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2008-05-12T22:41:51Z,,0,0,09000064805a699a
FDA-2007-E-0278-0004,FDA,FDA-2007-E-0278,USPTO to FDA Center for Drug Evaluation and Research - Letter,Other,LET-Letter,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2008-05-12T22:41:49Z,,0,0,090000648050af17
FDA-2007-E-0278-0003,FDA,FDA-2007-E-0278,Sloan-Kettering Institute for Cancer Research - Patent Term Extension Application,Other,APP-Application,2008-05-12T04:00:00Z,2008,5,2008-05-12T04:00:00Z,,2013-08-11T04:20:11Z,,0,0,09000064805a68d5